StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)

Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –

Anbio Biotechnology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Anbio Biotechnology's market cap was $176.87M on Nov 11, 2026, against $990.88M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$176.87M-86.1%
2025Dec 31, 2025$1.27B–

More Anbio Biotechnology figures

See a number that looks wrong?